| CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability MR Valashedi, AM Roushandeh, K Tomita, Y Kuwahara, ... Life sciences 304, 120704, 2022 | 22 | 2022 |
| Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters MR Valashedi, C Bamshad, N Najafi-Ghalehlou, A Nikoo, K Tomita, ... Human Cell 35 (4), 972-994, 2022 | 22 | 2022 |
| Cashing in on ferroptosis against tumor cells: Usher in the next chapter MR Valashedi, N Najafi-Ghalehlou, A Nikoo, C Bamshad, K Tomita, ... Life Sciences 285, 119958, 2021 | 20 | 2021 |
| Pharmacological targeting of ferroptosis in cancer treatment MR Valashedi, A Nikoo, N Najafi-Ghalehlou, K Tomita, Y Kuwahara, ... Current Cancer Drug Targets 22 (2), 108-125, 2022 | 12 | 2022 |
| ACE2 in SARS-CoV-2-Mediated COVID-19: A Brief Review PS Kozani, SD Shokoohi, N Baharifar, S Sheikhi, FK Shamsabadi, ... Trends in Medical Sciences 2 (4), 2022 | 1 | 2022 |
| Chimeric Antigen Receptor Delivery Approaches in the Era of Regulatory-Approved T-cell Products for Cancer Immunotherapy SD Shokoohi, M Sheikhi, PS Kozani, PS Kozani, MR Valashedi, ... Trends in Medical Sciences 3 (1), 2023 | | 2023 |
Mehryar Habibi RoudkenarGuilan University of Medical Sciences在 gums.ac.ir 的电子邮件经过验证
